AKAP12 in astrocytes induces barrier functions in human endothelial cells through protein kinase Cζ

FEBS Journal

Volumn 275, Issue 9, 2008, Pages 2338-2353

  Choi, Yoon Kyung ^a   Kim, Kyu Won ^a  

^a Seoul National University   (South Korea)

Author keywords

AKAP12 (A kinase anchor protein 12); Blood neural barrier; Protein kinase C ; Thrombospondin 1; Vascular endothelial growth factor

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 12; PROTEIN KINASE C EPSILON; RHO KINASE; SMALL INTERFERING RNA; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; ASTROCYTE; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CELL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

A KINASE ANCHOR PROTEINS; AMIDES; ASTROCYTES; BLOOD-RETINAL BARRIER; CELL CYCLE PROTEINS; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; ISOENZYMES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEINS; PYRIDINES; RNA INTERFERENCE; RNA, MESSENGER; THROMBOSPONDIN 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42449129214     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06387.x     Document Type: Article

References (53)

1. Abbott NJ, Ronnback L Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7, 41 53.
2. Zhang Y, Porat RM, Alon T, Keshet E Stone J (1999) Tissue oxygen levels control astrocyte movement and differentiation in developing retina. Brain Res Dev Brain Res 118, 135 145.
3. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T Keshet E (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15, 4738 4747.
4. Provis JM, Leech J, Diaz CM, Penfold PL, Stone J Keshet E (1997) Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res 65, 555 568.
5. Dvorak HF, Nagy JA, Feng D, Brown LF Dvorak AM (1999) Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237, 97 132.
6. Alon T, Hemo I, Itin A, Pe'er J, Stone J Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1, 1024 1028.
7. Vailhe B Feige JJ (2003) Thrombospondins as anti-angiogenic therapeutic agents. Curr Pharm Des 9, 583 588.
8. Hu CJ, Chen SD, Yang DI, Lin TN, Chen CM, Huang TH Hsu CY (2006) Promoter region methylation and reduced expression of thrombospondin-1 after oxygen-glucose deprivation in murine cerebral endothelial cells. J Cereb Blood Flow Metab 26, 1519 1526.
9. Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3, 422 433.
10. Rastinejad F, Polverini PJ Bouck NP (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345 355.
11. Gelman IH Gao L (2006) SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways. Mol Cancer Res 4, 151 158.
12. Gelman IH, Lee K, Tombler E, Gordon R Lin X (1998) Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS. Cell Motil Cytoskeleton 41, 1 17.
13. Lin X, Tombler E, Nelson PJ, Ross M Gelman IH (1996) A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem 271, 28430 28438.
14. Cheng C, Liu H, Ge H, Qian J, Qin J, Sun L Shen A (2007) Essential role of Src suppressed C kinase substrates in endothelial cell adhesion and spreading. Biochem Biophys Res Commun 358, 342 348.
15. Kaibuchi K, Kuroda S Amano M (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68, 459 486.
16. Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y Kaibuchi K (1997) Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275, 1308 1311.
17. Park JH, Okayama N, Gute D, Krsmanovic A, Battarbee H Alexander JS (1999) Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton. Am J Physiol 277, C1066 C1074.
18. Chapline C, Cottom J, Tobin H, Hulmes J, Crabb J Jaken S (1998) A major, transformation-sensitive PKC-binding protein is also a PKC substrate involved in cytoskeletal remodeling. J Biol Chem 273, 19482 19489.
19. Hayashi M, Sakata M, Takeda T, Tahara M, Yamamoto T, Minekawa R, Isobe A, Tasaka K Murata Y (2005) Hypoxia up-regulates hypoxia-inducible factor-1alpha expression through RhoA activation in trophoblast cells. J Clin Endocrinol Metab 90, 1712 1719.
20. Choi YK, Kim JH, Kim WJ, Lee HY, Park JA, Lee SW, Yoon DK, Kim HH, Chung H, Yu YS et al. (2007) AKAP12 regulates human blood-retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha. J Neurosci 27, 4472 4481.
21. Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ Kim KW (2003) SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 9, 900 906.
22. Parekh DB, Ziegler W Parker PJ (2000) Multiple pathways control protein kinase C phosphorylation. EMBO J 19, 496 503.
23. Wu HM, Yuan Y, Zawieja DC, Tinsley J Granger HJ (1999) Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol 276, H535 H542.
24. Haller H, Ziegler W, Lindschau C Luft FC (1996) Endothelial cell tyrosine kinase receptor and G protein-coupled receptor activation involves distinct protein kinase C isoforms. Arterioscler Thromb Vasc Biol 16, 678 686.
25. Li X, Hahn CN, Parsons M, Drew J, Vadas MA Gamble JR (2004) Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1. Blood 104, 1716 1724.
26. Haller H, Hempel A, Homuth V, Mandelkow A, Busjahn A, Maasch C, Drab M, Lindschau C, Jupner A, Vetter K et al. (1998) Endothelial-cell permeability and protein kinase C in pre-eclampsia. Lancet 351, 945 949.
27. Pal S, Datta K, Khosravi-Far R Mukhopadhyay D (2001) Role of protein kinase Czeta in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression. J Biol Chem 276, 2395 2403.
28. Datta K, Li J, Bhattacharya R, Gasparian L, Wang E Mukhopadhyay D (2004) Protein kinase C zeta transactivates hypoxia-inducible factor alpha by promoting its association with p300 in renal cancer. Cancer Res 64, 456 462.
29. Ferrara N, Gerber HP LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9, 669 676.
30. Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, Dye C, Yang J, Dai M, Ju X et al. (2006) Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol 26, 4240 4256.
31. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD Steeg PS (1994) Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54, 6504 6511.
32. Zhang YW, Su Y, Volpert OV Vande Woude GF (2003) Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci USA 100, 12718 12723.
33. Greenaway J, Gentry PA, Feige JJ, LaMarre J Petrik JJ (2005) Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development. Biol Reprod 72, 1071 1078.
34. Cho CH, Kammerer RA, Lee HJ, Steinmetz MO, Ryu YS, Lee SH, Yasunaga K, Kim KT, Kim I, Choi HH et al. (2004) COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci USA 101, 5547 5552.
35. Kuribayashi K, Nakamura K, Tanaka M, Sato T, Kato J, Sasaki K, Takimoto R, Kogawa K, Terui T, Takayama T et al. (2007) Essential role of protein kinase C zeta in transducing a motility signal induced by superoxide and a chemotactic peptide, fMLP. J Cell Biol 176, 1049 1060.
36. Van Kolen K Slegers H (2006) Atypical PKCzeta is involved in RhoA-dependent mitogenic signaling by the P2Y(12) receptor in C6 cells. FEBS J 273, 1843 1854.
37. Song HS, Son MJ, Lee YM, Kim WJ, Lee SW, Kim CW Kim KW (2002) Oxygen tension regulates the maturation of the blood-brain barrier. Biochem Biophys Res Commun 290, 325 331.
38. Jackson C (2002) Matrix metalloproteinases and angiogenesis. Curr Opin Nephrol Hypertens 11, 295 299.
39. West H, Richardson WD Fruttiger M (2005) Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development 132, 1855 1862.
40. Provis JM (2001) Development of the primate retinal vasculature. Prog Retin Eye Res 20, 799 821.
41. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD et al. (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42, 2408 2413.
42. Witmer AN, Vrensen GF, Van Noorden CJ Schlingemann RO (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22, 1 29.
43. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435 439.
44. Young TA, Wang H, Munk S, Hammoudi DS, Young DS, Mandelcorn MS Whiteside CI (2005) Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent. Exp Eye Res 80, 651 662.
45. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835 846.
46. Murphy-Ullrich JE Mosher DF (1987) Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation. J Cell Biol 105, 1603 1611.
47. Xu H, Czerwinski P, Hortmann M, Sohn HY, Forstermann U Li H (2008) Protein kinase C [alpha] promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovasc Res, doi :
48. Morcos Y, Hosie MJ, Bauer HC Chan-Ling T (2001) Immunolocalization of occludin and claudin-1 to tight junctions in intact CNS vessels of mammalian retina. J Neurocytol 30, 107 123.
49. Staddon JM Rubin LL (1996) Cell adhesion, cell junctions and the blood-brain barrier. Curr Opin Neurobiol 6, 622 627.
50. Gumbiner B Simons K (1986) A functional assay for proteins involved in establishing an epithelial occluding barrier: identification of a uvomorulin-like polypeptide. J Cell Biol 102, 457 468.
51. Gavard J Gutkind JS (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8, 1223 1234.
52. Moon EJ, Jeong CH, Jeong JW, Kim KR, Yu DY, Murakami S, Kim CW Kim KW (2004) Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J 18, 382 384.
53. Lee MS, Moon EJ, Lee SW, Kim MS, Kim KW Kim YJ (2001) Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res 61, 3290 3293.